All posts by: Michael Zand

Stem cell agency okays $32 million in new awards – Capitol Weekly

Stem cell agency okays $32 million in new awardsCapitol WeeklyStanford University researchers received $12.3 million and provided $2.3 million in matching funds for a a phase one trial for a CAR-T therapy for “patients with B cell leukemias who have re… Continue reading

T Cell Biomarker Predicts Which CLL Patients will Respond to CAR T Cell Therapy – Scicasts (press release) (blog)

Scicasts (press release) (blog)T Cell Biomarker Predicts Which CLL Patients will Respond to CAR T Cell TherapyScicasts (press release) (blog)While 80 percent of patients with advanced acute lymphoblastic leukemia (ALL) treated with the CAR T cell thera… Continue reading

T Cell Biomarker Predicts Which CLL Patients will Respond to CAR T Cell Therapy – Scicasts (press release) (blog)

Scicasts (press release) (blog)T Cell Biomarker Predicts Which CLL Patients will Respond to CAR T Cell TherapyScicasts (press release) (blog)While 80 percent of patients with advanced acute lymphoblastic leukemia (ALL) treated with the CAR T cell thera… Continue reading

Healthy Living: Stem Cell Therapy – 9 & 10 News – 9&10 News

Healthy Living: Stem Cell Therapy – 9 & 10 News – 9&10 News

Healthy T cells have a fighting chance for cell therapy – Penn: Office of University Communications

Healthy T cells have a fighting chance for cell therapyPenn: Office of University CommunicationsPatients with chronic lymphocytic leukemia (CLL) who have a healthy amount of T cells prior to treatment (“early memory” T cells) responded positively to … Continue reading

Healthy T cells have a fighting chance for cell therapy – Penn: Office of University Communications

Healthy T cells have a fighting chance for cell therapyPenn: Office of University CommunicationsPatients with chronic lymphocytic leukemia (CLL) who have a healthy amount of T cells prior to treatment (“early memory” T cells) responded positively to … Continue reading